Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Spok HoldingsFRA:FQV +1.08%62 5-Year Yield-on-Cost % is 33.14 as of Jul. 30, 2026, which is 124% above its 10-year median of 14.82. GuruFocus rates FRA:FQV with a GF Score™ of 62/100 and a GF Value™ of €12.64 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 276 Healthcare Providers & Services companies, Spok Holdings ranks better than 98.19% on this metric.
Spok Holdings's yield on cost for the quarter that ended in Mar. 2026 was 33.14.
The historical rank and industry rank for Spok Holdings's 5-Year Yield-on-Cost % or its related term are showing as below:
FRA:FQV'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 6.7 Med: 14.82 Max: 43.26
Current: 33.14
During the past 13 years, Spok Holdings's highest Yield on Cost was 43.26. The lowest was 6.70. And the median was 14.82.
FRA:FQV's 5-Year Yield-on-Cost % is ranked better than 98.19% of 276
companies
in the Healthcare Providers & Services industry
Industry Median: 2.945
vs FRA:FQV: 33.14
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Spok Holdings 5-Year Yield-on-Cost % Related Terms
FRA:FQV vs SY, AMWL, LFMD: 5-Year Yield-on-Cost % Comparison
For the Health Information Services subindustry, Spok Holdings's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Spok Holdings 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Spok Holdings's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Spok Holdings's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Spok Holdings is calculated as
Spok Holdings (FRA:FQV) has a 5-Year Yield-on-Cost % of 33.14 as of Jul. 30, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Spok Holdings and its competitors. This is 124% above median its historical median of 14.82. Over the past decade, Spok Holdings' 5-Year Yield-on-Cost % has ranged from 6.70 to 43.26. According to the industry distribution chart, Spok Holdings ranks #5 out of 276 companies in the Healthcare Providers & Services industry, placing it in the top 1.8%.
Is Spok Holdings' 5-Year Yield-on-Cost % too high?
Spok Holdings' current 5-Year Yield-on-Cost % of 33.14 is 124% above median its 10-year median of 14.82. Over the past 10 years, this metric has ranged from a low of 6.70 to a high of 43.26. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.95. Spok Holdings' value of 33.14 is 1025.3% above this industry median. Based on the distribution chart, Spok Holdings ranks #5 out of 276 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Spok Holdings has a GF Score™ of 62/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Spok Holdings' 5-Year Yield-on-Cost % compare to SY and AMWL?
According to the Healthcare Providers & Services industry distribution chart, Spok Holdings ranks #5 out of 276 companies for 5-Year Yield-on-Cost %. This places Spok Holdings in the top 2% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.95. Spok Holdings' value of 33.14 is 1025.3% above this benchmark. Historically, Spok Holdings' own 5-Year Yield-on-Cost % has ranged from 6.70 to 43.26 over the past decade. While the company's 10-year median is 14.82 vs. the industry median of 2.95, Spok Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.95, based on 276 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Spok Holdings's current 5-Year Yield-on-Cost % of 33.14 is 1025.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Spok Holdings and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Spok Holdings's current 5-Year Yield-on-Cost % is 33.14, which is 124% above median its own 10-year median of 14.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Spok Holdings stock overvalued right now?
Based on GuruFocus' analysis, Spok Holdings (FRA:FQV) is currently considered Modestly Undervalued. The stock's GF Value™ is €12.64, compared to a current price of €9.40 — trading 25.6% below its estimated fair value. The current 5-Year Yield-on-Cost % is 33.14, which is 124% above median its 10-year median of 14.82 and 1025.3% above the Healthcare Providers & Services industry median of 2.95. Spok Holdings' overall GF Score™ is 62/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Spok Holdings (FRA:FQV), the current 5-Year Yield-on-Cost % is 33.14 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Spok Holdings (FRA:FQV) Overvalued in 2026?
Based on GuruFocus' analysis, Spok Holdings stock appears to be undervalued.
The current stock price of €9.40 is trading 25.6% below its estimated GF Value™ of €12.64.
GuruFocus considers Spok Holdings to be Modestly Undervalued.
Key valuation signals for FRA:FQV:
5-Year Yield-on-Cost %: 33.14 (124% above median its 10-year median of 14.82)
GF Value™: €12.64 vs. price of €9.40 (25.6% below fair value)
Industry Position: 1025.3% above the Healthcare Providers & Services median (#5 of 276)
No single metric tells the full story. See the FRA:FQV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.
62GF Score
Get the complete analysis for FRA:FQV
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:FQV has been successfully added to your 
